UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 430

Sortiert nach

1228 Comprehensive T-cell Profiling in Chordomas: Single-cell RNA-Seq and TCR Profiling Analysis Uncover Antitumor and Exhaustion Phenotypes for Targeted Immunotherapies

Neurosurgery, 2024-04, Vol.70 (Supplement_1), p.190-190

2024

Volltextzugriff (PDF)

2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations

PloS one, 2011-02, Vol.6 (2), p.e16812-e16812

2011

Volltextzugriff (PDF)

22. A Novel Single-Chain Antibody for Selective Targeting of IL13Ra2-Expressing Brain Tumors

Molecular therapy, 2015-05, Vol.23, p.S10-S10

2015

Volltextzugriff (PDF)

356 Quantitative Magnetization Transfer MRI Measurements of the Anterior Spinal Cord Region are Associated with Clinical Outcomes in Cervical Spondylotic Myelopathy

Neurosurgery, 2017-09, Vol.64 (CN_suppl_1), p.281-282

2017

Volltextzugriff (PDF)

537. Transcriptionally Targeting the Survivin Promoter to Human Gliomas

Molecular therapy, 2005-05, Vol.11 (S1), p.S208-S208

2005

Volltextzugriff (PDF)

Abstract 1091: CCR4+ regulatory T cells progressively accumulate in the presence of leukocyte-derived CCL22/CCL17 in an experimental model of glioblastoma multiforme

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1091-1091

2014

Volltextzugriff (PDF)

Abstract 1439: Clinical significance of KISS1 protein expression in breast cancer metastasis to brain

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1439-1439

2011

Volltextzugriff (PDF)

Abstract 2006: The role of neuronal predominant gene expression in breast cancer brain metastasis

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2006-2006

2014

Volltextzugriff (PDF)

Abstract 2548: The central nervous system immune cell interactome is a function of cancer lineage, tumor microenvironment and STAT3 expression

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2548-2548

2022

Volltextzugriff (PDF)

Abstract 2798: Targeting IL13R alpha2 heterogeneity in malignant glioma with engineered T cells

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2798-2798

2014

Volltextzugriff (PDF)

Abstract 3487: Distant delivery of glioma-restricted oncolytic adenovirus loaded into a neural stem cell-based carrier prolongs the survival of animals with human glioblastoma

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3487-3487

2012

Volltextzugriff (PDF)

Abstract 3899: ROCK inhibitor as a differentiation-inducing agent to target glioma stem cells

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3899-3899

2014

Volltextzugriff (PDF)

Abstract 4315: A novel role for the high affinity IL13 receptor in glioblastoma multiforme

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4315-4315

2012

Volltextzugriff (PDF)

Abstract 5021: Temozolomide-induced conversion of glioma cells into glioma “stem-like” cells with enhanced invasion properties

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.5021-5021

2013

Volltextzugriff (PDF)

Abstract A36: Fibronectin promotes glioma progression by modulating survivin expression and regulatory T cell infiltration

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (23_Supplement), p.A36-A36

2009

Volltextzugriff (PDF)

Abstract B034: Targeting cellular plasticity-driven metabolic adaptation to overcome chemoresistance in GBM

Cancer research (Chicago, Ill.), 2022-05, Vol.82 (10_Supplement), p.B034-B034

2022

Volltextzugriff (PDF)

Abstract B36: Nano-engineering of immunosuppressive myeloid cells for immunostimulation in glioblastoma

Cancer immunology research, 2022-12, Vol.10 (12_Supplement), p.B36-B36

2022

Volltextzugriff (PDF)

Abstract B95: PD-L1-mediated nanotherapeutic targeting of glioma-infiltrating myeloid cells synergizes with radiotherapy for glioblastoma

Cancer immunology research, 2020-03, Vol.8 (3_Supplement), p.B95-B95

2020

Volltextzugriff (PDF)

Abstract LB-64: Immune modulatory effects of mesenchymal stem cells on regulatory T cells in mouse glioma model

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.LB-64-LB-64

2014

Volltextzugriff (PDF)

Abstract LB335: Establishment of the effective dose of the STAT3 inhibitor WP1066 used in combination with STING activation for reprograming the preclinical glioma microenvironment

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.LB335-LB335

2023

Volltextzugriff (PDF)

Abstract PR011: Targeting cellular plasticity-driven metabolic adaptation to overcome chemoresistance in GBM

Cancer research (Chicago, Ill.), 2022-05, Vol.82 (10_Supplement), p.PR011-PR011

2022

Volltextzugriff (PDF)

Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma

The Journal of experimental medicine, 2021-01, Vol.218 (1)

2021

Volltextzugriff (PDF)

Activation of a helper and not regulatory human CD4+ T cell response by oncolytic H-1 parvovirus

PloS one, 2012-02, Vol.7 (2), p.e32197-e32197

2012

Volltextzugriff (PDF)

Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma

The Journal of neuroscience, 2019-03, Vol.39 (11), p.1982-1993

2019

Volltextzugriff (PDF)

Activation of p53 by nutlin-3a induces apoptosis and cellular senescence in human glioblastoma multiforme

PloS one, 2011-04, Vol.6 (4), p.e18588-e18588

2011

Volltextzugriff (PDF)

1 – 25 von 430

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(402)
Mit Volltextzugriff
(395)

Publikationsform

Sprache

Englisch
(427)
Japanisch
(66)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(302)
Humans
(253)
Life Sciences & Biomedicine
(210)
Animals
(161)
Mice
(117)
Brain Cancer
(102)
Oncology
(100)
Science & Technology - Other Topics
(90)
Glioma
(88)
Tumors
(86)
Multidisciplinary Sciences
(81)
Cell Line, Tumor
(80)
Glioblastoma
(77)
Female
(76)
Male
(73)
Brain Tumors
(68)
Brain Neoplasms - Therapy
(67)
Medicine
(63)
Brain Neoplasms - Pathology
(59)
Cancer
(57)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

1228 Comprehensive T-cell Profiling in Chordomas: Single-cell RNA-Seq and TCR Profiling Analysis Uncover Antitumor and Exhaustion Phenotypes for Targeted Immunotherapies

2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations

22. A Novel Single-Chain Antibody for Selective Targeting of IL13Ra2-Expressing Brain Tumors

356 Quantitative Magnetization Transfer MRI Measurements of the Anterior Spinal Cord Region are Associated with Clinical Outcomes in Cervical Spondylotic Myelopathy

537. Transcriptionally Targeting the Survivin Promoter to Human Gliomas

Abstract 1091: CCR4+ regulatory T cells progressively accumulate in the presence of leukocyte-derived CCL22/CCL17 in an experimental model of glioblastoma multiforme

Abstract 1439: Clinical significance of KISS1 protein expression in breast cancer metastasis to brain

Abstract 2006: The role of neuronal predominant gene expression in breast cancer brain metastasis

Abstract 2548: The central nervous system immune cell interactome is a function of cancer lineage, tumor microenvironment and STAT3 expression

Abstract 2798: Targeting IL13R alpha2 heterogeneity in malignant glioma with engineered T cells

Abstract 3487: Distant delivery of glioma-restricted oncolytic adenovirus loaded into a neural stem cell-based carrier prolongs the survival of animals with human glioblastoma

Abstract 3899: ROCK inhibitor as a differentiation-inducing agent to target glioma stem cells

Abstract 4315: A novel role for the high affinity IL13 receptor in glioblastoma multiforme

Abstract 5021: Temozolomide-induced conversion of glioma cells into glioma “stem-like” cells with enhanced invasion properties

Abstract A36: Fibronectin promotes glioma progression by modulating survivin expression and regulatory T cell infiltration

Abstract B034: Targeting cellular plasticity-driven metabolic adaptation to overcome chemoresistance in GBM

Abstract B36: Nano-engineering of immunosuppressive myeloid cells for immunostimulation in glioblastoma

Abstract B95: PD-L1-mediated nanotherapeutic targeting of glioma-infiltrating myeloid cells synergizes with radiotherapy for glioblastoma

Abstract LB-64: Immune modulatory effects of mesenchymal stem cells on regulatory T cells in mouse glioma model

Abstract LB335: Establishment of the effective dose of the STAT3 inhibitor WP1066 used in combination with STING activation for reprograming the preclinical glioma microenvironment

Abstract PR011: Targeting cellular plasticity-driven metabolic adaptation to overcome chemoresistance in GBM

Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma

Activation of a helper and not regulatory human CD4+ T cell response by oncolytic H-1 parvovirus

Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma

Activation of p53 by nutlin-3a induces apoptosis and cellular senescence in human glioblastoma multiforme

Suchergebnisse filtern